Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
In light of the differences in gene expression and metabolic function of visceral (V) and subcutaneous (S) adipose tissue (AT) and their resident cells, the aim of this study was to investigate the role of SIRT1 and SIRT2 in the differentiation of adipose stem cells (ASCs) isolated from SAT and VAT biopsies of nondiabetic obese and nonobese individuals.
|
31462690 |
2020 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
SIRT1 and SIRT2 expression and AMPK levels decrease in children with obesity and IR.
|
29150224 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
In elafibranor-treated HFD mice, increased insulin sensitivity, reduced obesity and body fat mass, decreased severity of steatohepatitis, increased renal expression of PPAR<i>α</i>, PPAR<i>δ</i>, SIRT1, and autophagy (Beclin-1 and LC3-II) as well as glomerular/renal tubular barrier markers [synaptopodin (podocyte marker), zona occludin-1, and cubulin], reduced renal oxidative stress and caspase-3, and less urinary 8-isoprostanes excretion were observed.
|
31321239 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
These results help to understand SIRT1-based strategy for treating vascular and metabolic dysfunction in the context of obesity and insulin resistance.
|
30503839 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
The <i>Sir2/Sirt1</i> gene overexpression delays cell aging and reduces obesity and oxidative stress.
|
31503544 |
2019 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
To investigate the effects of obesity caused by high-fat diet (HFD) on postoperative cognitive dysfunction (POCD) and expression of the Sirt1/PGC-1α/FNDC5/BDNF pathway in the hippocampus of older mice.
|
30794116 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated the role of SIRT1 in the development of obesity and insulin resistance by generating mice with adipose-specific ablation of <i>Sirt1</i> (Ad-<i>Sirt1</i><sup>-/-</sup> mice).
|
31296102 |
2019 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Licochalcone A can potentially ameliorate obesity and NAFLD in mice via activation of the sirt1/AMPK pathway.
|
31083505 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
Thereby, we posited that enhanced EnNaC activation contributes to diet induced obesity related increases in stiffness of the endothelium and diminished NO mediated vascular relaxation by increasing oxidative stress and related inhibition of AMPKα, Sirt1, and associated eNOS inactivation.
|
31302199 |
2019 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Tartary Buckwheat Extract Attenuated the Obesity-Induced Inflammation and Increased Muscle PGC-1a/SIRT1 Expression in High Fat Diet-Induced Obese Rats.
|
30889894 |
2019 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Excess circulating fat, as seen in obesity, has been shown to decrease β-cell function, an effect that may involve decreased SIRT1 activity.
|
30890694 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
Activation of SirT1 mitigates metabolic perturbations associated with diabetes and obesity.
|
30877853 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
Conclusion: Peripheral CB<sub>1</sub> R blockade in mice with obesity improves glycemic control through the hepatic Sirt1/mTORC2/Akt pathway, whereas it increases fatty acid oxidation through LKB1/AMPK signaling.
|
30506571 |
2019 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
In this review, we will first summarize how SIRT1 in the brain relates to obesity, type 2 diabetes, and circadian synchronization, and then we discuss the neuroprotective roles of brain SIRT1 in the context of cerebral ischemia and neurodegenerative disorders.
|
30532738 |
2018 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression.
|
30305620 |
2018 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
In mesenteric white adipose tissue and skeletal muscle, the administration of SM activated AMP-activated protein kinase (AMPK) pathway and sirtuin 1 (SIRT1), leading to the suppression of the development of pathophysiological mechanism associated with obesity, including promoted lipid synthesis and blocked lipid oxidation.
|
30178808 |
2018 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
These results suggest that CD38 deficiency impairs adipogenesis and lipogenesis through activating Sirt1/PPARγ-FASN signalling pathway during the development of obesity.
|
28816006 |
2018 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Here, we provide an overview of the association of the increasing level of SIRT1 protein for regulating some disease related conditions such as obesity, cardiovascular diseases and neurodegeneration.
|
30374331 |
2018 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
Here, we found that miR-221 negatively regulated SIRT1 in white adipose tissue during inflammation and HFD-induced obesity.
|
29236311 |
2018 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery.
|
29428938 |
2018 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
Pinitol alleviates systemic inflammatory cytokines in human obesity by a mechanism involving unfolded protein response and sirtuin 1.
|
29042127 |
2018 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
|
28592311 |
2017 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
TRPV1 activation counters diet-induced obesity through sirtuin-1 activation and PRDM-16 deacetylation in brown adipose tissue.
|
28104916 |
2017 |
Obesity
|
0.600 |
Biomarker
|
disease |
BEFREE |
These findings indicate that zerumbone ameliorated diet-induced obesity and inhibited adipogenesis, and that the underlying mechanisms involved AMPK and the microRNA-146b/SIRT1 pathway.
|
28445161 |
2017 |
Obesity
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways.
|
28950020 |
2017 |